Pediatric Medical Oncology

Fingerprint Dive into the research topics where Pediatric Medical Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Idiopathic Thrombocytopenic Purpura Medicine & Life Sciences
Platelet Count Medicine & Life Sciences
Decision Making Medicine & Life Sciences
Physicians Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Quality of Life Medicine & Life Sciences
Patient Preference Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

1 Citation (Scopus)

Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes

Grace, R. F., Shimano, K. A., Bhat, R., Neunert, C., Bussel, J. B., Klaassen, R. J., Lambert, M. P., Rothman, J. A., Breakey, V. R., Hege, K., Bennett, C. M., Rose, M. J., Haley, K. M., Buchanan, G. R., Geddis, A., Lorenzana, A., Jeng, M., Pastore, Y. D., Crary, S. E., Neier, M. & 4 others, Neufeld, E. J., Neu, N., Forbes, P. W. & Despotovic, J. M., Jul 2019, In : American Journal of Hematology. 94, 7, p. 741-750 10 p.

Research output: Contribution to journalArticle

Open Access
Idiopathic Thrombocytopenic Purpura
Platelet Count
Hemorrhage
Quality of Life
Therapeutics
7 Citations (Scopus)

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children

Grace, R. F., Despotovic, J. M., Bennett, C. M., Bussel, J. B., Neier, M., Neunert, C., Crary, S. E., Pastore, Y. D., Klaassen, R. J., Rothman, J. A., Hege, K., Breakey, V. R., Rose, M. J., Shimano, K. A., Buchanan, G. R., Geddis, A., Haley, K. M., Lorenzana, A., Thompson, A., Jeng, M. & 4 others, Neufeld, E. J., Brown, T., Forbes, P. W. & Lambert, M. P., Jul 2018, In : American Journal of Hematology. 93, 7, p. 882-888 7 p.

Research output: Contribution to journalArticle

Idiopathic Thrombocytopenic Purpura
Decision Making
Physicians
Patient Preference
Therapeutics